$86.30
0.190.22%
al cierre: -
$86.30
N/A
After hour: Nov 14, 4:00 PM EDT
Comments
Loading...
Orientación y previsiones
Edwards Lifesciences emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.56 | $2.62 | $2.51 | $5.93B | $6.10B | $5.98B | |
10/30/2025 | EW | Edwards Lifesciences | Q4 | 2025 | $0.58 | $0.64 | $0.59 | $1.51B | $1.59B | $1.50B | |
08/06/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.45 | $2.55 | $2.49 | — | — | — | |
07/24/2025 | EW | Edwards Lifesciences | Q3 | 2025 | $0.54 | $0.60 | $0.62 | $1.46B | $1.54B | $1.49B | |
07/24/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.90B | $6.10B | $5.90B | |
04/23/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.70B | $6.10B | $5.82B | |
04/23/2025 | EW | Edwards Lifesciences | Q2 | 2025 | $0.59 | $0.65 | $0.62 | $1.45B | $1.53B | $1.46B | |
02/11/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.60B | $6.00B | $5.84B | |
02/11/2025 | EW | Edwards Lifesciences | Q1 | 2025 | $0.58 | $0.64 | $0.59 | $1.35B | $1.43B | $1.42B | |
12/04/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $5.83B | |
12/04/2024 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.60B | $6.00B | $5.92B | |
10/24/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $6.13B | |
10/24/2024 | EW | Edwards Lifesciences | Q4 | 2024 | $0.53 | $0.57 | $0.62 | $1.33B | $1.39B | $1.44B | |
07/24/2024 | EW | Edwards Lifesciences | Q3 | 2024 | $0.67 | $0.71 | $0.69 | $1.56B | $1.64B | $1.62B | |
04/25/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.75 | $6.60B | $6.60B | $6.52B | |
04/25/2024 | EW | Edwards Lifesciences | Q2 | 2024 | $0.67 | $0.71 | $0.70 | $1.62B | $1.70B | $1.64B | |
02/06/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.76 | $6.30B | $6.60B | $6.48B | |
02/06/2024 | EW | Edwards Lifesciences | Q1 | 2024 | $0.62 | $0.66 | $0.66 | $1.53B | $1.61B | $1.56B | |
12/07/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.47 | $2.53 | $2.51 | $5.90B | $6.10B | $5.97B | |
12/07/2023 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.80 | $6.30B | $6.60B | $6.51B | |
10/25/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.92B | $6.08B | $6.00B | |
10/25/2023 | EW | Edwards Lifesciences | Q4 | 2023 | $0.60 | $0.66 | $0.68 | $1.45B | $1.53B | $1.54B | |
07/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.90B | $6.10B | $5.96B | |
07/26/2023 | EW | Edwards Lifesciences | Q3 | 2023 | $0.55 | $0.61 | $0.63 | $1.44B | $1.52B | $1.47B | |
04/26/2023 | EW | Edwards Lifesciences | Q2 | 2023 | $0.62 | $0.68 | $0.63 | $1.48B | $1.56B | $1.46B | |
04/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.48 | $2.60 | $2.52 | $6.00B | $6.00B | $5.85B | |
01/31/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.50 | $5.60B | $6.00B | $5.78B | |
01/31/2023 | EW | Edwards Lifesciences | Q1 | 2023 | $0.58 | $0.64 | $0.59 | $1.37B | $1.45B | $1.37B | |
12/08/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.45 | $5.35B | $5.35B | $5.36B | |
12/08/2022 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.52 | $5.60B | $6.00B | $5.71B | |
10/27/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.51 | $5.35B | $5.35B | $5.47B | |
07/28/2022 | EW | Edwards Lifesciences | Q3 | 2022 | $0.58 | $0.66 | $0.65 | $1.30B | $1.37B | $1.44B | |
07/28/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.50 | $2.56 | $5.35B | $5.55B | $5.71B | |
04/26/2022 | EW | Edwards Lifesciences | Q2 | 2022 | $0.61 | $0.69 | $0.65 | $1.36B | $1.44B | $1.46B | |
04/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.55 | $5.50B | $6.00B | $5.76B | |
01/26/2022 | EW | Edwards Lifesciences | Q1 | 2022 | $0.54 | $0.62 | $0.60 | $1.27B | $1.35B | $1.36B | |
01/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.82B | |
12/08/2021 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.85B |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Edwards Lifesciences (EW)?
La orientación más reciente para Edwards Lifesciences (EW) se informó el octubre 30, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $2.56 a $2.62, en comparación con el EPS estimado de $2.51. Además, Edwards Lifesciences pronosticó ingresos entre $5.93B y $6.10B para el trimestre.
Explora orientación y previsión sobre todos los valores.